Eleven Biotherapeutics Inc (NASDAQ:EBIO)

11.03
Delayed Data
As of Mar 04
 0.00 / 0.00%
Today’s Change
9.50
Today|||52-Week Range
17.82
-7.15%
Year-to-Date
No recent news for Eleven Biotherapeutics Inc.

Today’s Trading

Previous close11.03
Today’s openn.a.
Day’s range-- - --
Volume0
Average volume (3 months)27,870
Market cap$177.7M
Dividend yield--
Data as of 03/04/2015

Growth & Valuation

Earnings growth (last year)+93.81%
Earnings growth (this year)+87.12%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ARGSArgos Therapeutics I...0.000.00%
SYNSynthetic Biologics ...-0.01-0.42%
MSLIMerus Labs Internati...+0.01+0.48%
NHTCNatural Health Trend...-0.39-2.47%
Data as of 9:50am ET, 03/05/2015

Financials

Last reporting dateMarch 5, 2015
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$1.3M
Annual profit (last year)-$18.0M
Net profit margin-1,351.20%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Abbie C. Celniker
Chief Financial &
Business Officer
Gregory D. Perry
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account